GC-MS: The yin to LC-MS's yang
GC-MS is the yin to LC-MS’s yang. Where LC-MS is solvent-based, GC-MS is a gas-phase technique. As a... more »

Lipidomics: A Decade of Growth
Though once regarded largely as cellular junk, material to be eliminated before getting to the more ... more »

NEWSLETTER SPONSOR

Advertisement

Accelerate Your Drug Development
from Bio-Rad
Get the data you need earlier with new Bio-Plex Pro™ RBM kidney toxicity assays. These magnetic multiplex assays detect and quantify the most relevant biomarkers for kidney injury and damage, providing valuable information throughout drug development — from lead optimization to preclinical and clinical protocol decision making. Available for use with human, canine, and rat urine samples. more »

Fibroblast Growth Factors
Gold Biotechnology
Goldbio’s new recombinant proteins include Fibroblast Growth Factors (FGF). The FGF family is ... more »

Monolith NT.115 Series Microscale Thermophoresis Instrument
NanoTemper Technologies
NanoTemper offers two types of instruments in the Monolith Series. The NT.115 works with fluorescent... more »

Amersham ECL Gel Box from GE Healthcare Life Sciences
This product from Amersham is for separation of proteins using horizontal mini-polyacrylamide gel ... more »

Purified Mouse Anti-human HLA-A2, clone BB7.2 from BD Biosciences
BB7.2 is an example of a polymorphic antibody that recognizes epitopes carried by subsets of HLA ... more »

New Therapy Is Tolerable In Lung Cancer more »

UCLA-Led Team May Have Found Key To Cause Of Cushing Disease more »

Ketamine Cousin Rapidly Lifts Depression Without Side Effects more »

No Benefit Of Double Dose Antiviral Drug For Severe Influenza more »

Quitting Smoking: Licensed Medications Are Effective more »

NIH Begins Recruitment For Long-Term Study Of Diabetes Drug Efficacy more »

Risk Of Kidney Disease Doubled With Use Of Fluoroquinolone Antibiotics more »

New Drug Improves Progression-Free Survival, Shrinks Tumors In Rare Cancer For First Time more »

Potential New Way To Suppress Tumor Growth Discovered more »

NIH To Fund Clinical Research Network On Antibacterial Resistance more »

FDA Panel Revisits Avandia, Likely Too Late For Diabetes Drug more »

FDA Wins Temporary Halt On Some Morning-After Pills more »

Not Really 'Bath Salts' -- paper Provides Update On 'Designer Stimulants' more »

Alzheimer's Disease Drugs Linked To Reduced Risk Of Heart Attacks more »